Multi-Cancer Early Detection Through Novel Blood Tests: Developing Appropriate Regulatory and Reimbursement Pathways

Virtual Event (ET)

James A. Boiani, Member of the Firm, will participate on a panel, “Multi-Cancer Early Detection Through Novel Blood Tests: Developing Appropriate Regulatory and Reimbursement Pathways,” a two part discussion on accelerating innovation and high-value care, which convenes on September 30 and October 8, hosted by Network for Excellence in Health Innovation (NEHI) with support from the Grail and Thrive Earlier Detection organizations.

For more information, please contact Mr. Boiani